Comments
Loading...
Galmed Pharmaceuticals (GLMD) Forecast
NewsEarningsGalmed Pharmaceuticals (GLMD) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestGalmed Pharmaceuticals (NASDAQ:GLMD) Stock Quotes, Forecast and News Summary
Galmed Pharmaceuticals Stock (NASDAQ: GLMD) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Galmed Pharmaceuticals (GLMD) stock?
You can purchase shares of Galmed Pharmaceuticals (NASDAQ:GLMD) through any online brokerage.
Who are Galmed Pharmaceuticals (GLMD) competitors?
There are no as such competitors for Galmed Pharmaceuticals.
What is the forecast, or price target, for Galmed Pharmaceuticals (GLMD) stock?
Galmed Pharmaceuticals has a consensus price target of $2.50.
What is the current price for Galmed Pharmaceuticals (GLMD)?
The stock price for Galmed Pharmaceuticals (NASDAQ: GLMD) is $2.84 last updated November 21, 2024 at 1:19 PM EST.
Does Galmed Pharmaceuticals (GLMD) pay a dividend?
There are no upcoming dividends for Galmed Pharmaceuticals.
When is Galmed Pharmaceuticals (NASDAQ:GLMD) reporting earnings?
Galmed Pharmaceuticals’s Q2 earnings are confirmed for Tuesday, December 3, 2024.
Is Galmed Pharmaceuticals (GLMD) going to split?
There is no upcoming split for Galmed Pharmaceuticals.
What sector and industry does Galmed Pharmaceuticals (GLMD) operate in?
Galmed Pharmaceuticals is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.